Natalie Lowry

Superiority and cost-effectiveness of monthly extended-release buprenorphine versus daily standard of care medication: a pragmatic, parallel-group, open-label, multicentre, randomised, controlled, phase 3 trial

John Marsden, Mike Kelleher, Éilish Gilvarry et al. · EClinicalMedicine · 2023 · 34 citations · Full text

Acute impact of self‐guided mental imagery on craving in cocaine use disorder: a mixed‐methods analysis of a randomized controlled trial

Natalie Lowry, John Marsden, Bethany Clydesdale et al. · Addiction · 2021 · 16 citations · Full text

Ultra-processed food intake in toddlerhood and mid-childhood in the UK: cross sectional and longitudinal perspectives

Rana Conway, Gabriella N Heuchan, Lisa Heggie et al. · European Journal of Nutrition · 2024 · 13 citations · Full text

Extended-release pharmacotherapy for opioid use disorder (EXPO): protocol for an open-label randomised controlled trial of the effectiveness and cost-effectiveness of injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadone

John Marsden, Mike Kelleher, Zoë Hoare et al. · Trials · 2022 · 11 citations · Full text

Patients’ perceptions of self-administered dosing to opioid agonist treatment and other changes during the COVID-19 pandemic: a qualitative study

Gemma Scott, Sophie Turner, Natalie Lowry et al. · BMJ Open · 2023 · 10 citations · Full text